Diproqualone

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Diproqualone
Diproqualone.svg
Systematic (IUPAC) name
3-(2,3-dihydroxypropyl)-2-methyl-quinazolin-4-one
Clinical data
Legal status ?
Identifiers
CAS number 36518-02-2 YesY
ATC code None
PubChem CID 64112
ChemSpider 57691 YesY
UNII QY7HLH8V4L YesY
Chemical data
Formula C12H14N2O3 
Mol. mass 234.251
 YesY (what is this?)  (verify)

Diproqualone is an analogue of methaqualone developed in the late 1950s by a team at Nogentaise de Produits Chimique. It was mainly marketed mainly in France and some other European countries. It has sedative, anxiolytic, antihistamine and analgesic properties, and is used primarily for the treatment of inflammatory pain associated with osteoarthritis and rheumatoid arthritis,[1] and more rarely for treating insomnia, anxiety and neuralgia.

Diproqualone is the only analogue of methaqualone that is still in widespread clinical use, due to its useful anti-inflammatory and analgesic effects in addition to the sedative and anxiolytic actions common to other drugs of this class. There are still some concerns about the potential of diproqualone for abuse and overdose, and so it is not sold as a pure drug but only as the camphosulfonate salt in combination mixtures with other medicines such as ethenzamide.

See also[edit]

References[edit]

  1. ^ Audeval B, Bouchacourt P, Rondier J. Comparative study of diproqualone-ethenzamide versus glafenine for the treatment of rheumatic pain of gonarthrosis and coxarthrosis. (French) Gazette médicale de France 1988; 95(25):70-72